ETH-LAD
Jump to navigation
Jump to search
| File:ETH-LAD.svg | |
| Gene therapy | |
|---|---|
| Clinical data | |
| Other names | ETH-LAD, 6-ethyl-6-nor-Lysergic acid diethylamide |
| Routes of administration | Oral |
| Physiological data | |
| Legal status | |
| Pharmacokinetic data | |
| Metabolism | hepatic |
| Excretion | renal |
| Identifiers | |
| Chemical and physical data | |
| Formula | C21H27N3O |
| Molar mass | 337.47 g/mol |
ETH-LAD, 6-ethyl-6-nor-lysergic acid diethylamide is an analogue of LSD. It is described by Alexander Shulgin in the book TiHKAL. ETH-LAD is a hallucinogenic drug similar to LSD, and is slightly more potent than LSD itself with an active dose reported at between 40 and 150 micrograms. ETH-LAD has subtly different effects to LSD, described as less demanding.
ETH-LAD has been sold by some research chemical suppliers but might be considered illegal in some countries due to its structural similarity to LSD.
External Links
Template:Pharmacology-stub Template:TiHKAL Template:Hallucinogenic lysergamides Template:WikiDoc Sources
Categories:
- Articles with short description
- Pages with broken file links
- Infobox-drug molecular-weight unexpected-character
- Pages using infobox drug with unknown parameters
- Chemical articles without CAS registry number
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs missing an ATC code
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Psychedelics
- Lysergamides